Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Polymerase chain reaction (PCR) test detects more oesophageal cancers:

This article was originally published in Clinica

Executive Summary

Testing for the biochemical marker carcinoembryonic antigen (CEA) could increase the detection of cancer spread from the oesophagus, US researchers have said. Using reverse transcriptase PCR, researchers at the University of Pittsburgh analysed 123 lymph nodes from 30 patients with oesophageal cancer. Of the 73 nodes that were negative on histology, 33 were found to have CEA mRNA and would therefore be classed as node-positive tumours. Use of the test increased the number of node-positive tumours from 41% to 70%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080499

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel